Page last updated: 2024-11-08

threitol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

threitol: RN given refers to (R*,R*)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-threitol : The D-enantiomer of threitol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID169019
CHEBI ID48300
SCHEMBL ID17766
MeSH IDM0044516

Synonyms (42)

Synonym
d-threitol, 99%
dl-threitol, 97%
threitol
d-threo-tetritol
d-threitol
(2r,3r)-butane-1,2,3,4-tetrol
2418-52-2
CHEBI:48300 ,
082CB5C6-FE44-4BE0-BEE0-8575D840C94A
dl-threitol
C16884
A817134
7493-90-5
1,2,3,4-butanetetrol, (r*,r*)-
1,2,3,4-butanetetrol, (2r,3r)-
threitol, d-
unii-6dn82xbt5m
1,2,3,4-butanetetrol, (r-(r*,r*))-
6dn82xbt5m ,
(2r,3r)-1,2,3,4-butanetetrol
EPITOPE ID:114709
threitol [inci]
SCHEMBL17766
UNXHWFMMPAWVPI-QWWZWVQMSA-N
3vb ,
W-202006
mfcd00067036
d-threitol, >=98.0% (sum of enantiomers, tlc)
AKOS027320419
(r*,r*)-1,2,3,4-butanetetrol
(-)-threitol
threit
AS-61771
CS-W013562
HY-W012846
rel-(2r,3r)-butane-1,2,3,4-tetraol
(2r,3r)-butane-1,2,3,4-tetraol
Q415347
DTXSID801016717
F85623
1,2,3,4-butanetetrol, [r-(r*,r*)]-
DTXSID801336604
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
threitol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
D-threitol degradation310

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (18.42)18.7374
1990's3 (7.89)18.2507
2000's17 (44.74)29.6817
2010's10 (26.32)24.3611
2020's1 (2.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.38 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]